Our latest article “Pharmacovigilance Obligations of Marketing Authorisation Holders” by Nihan Bacanak, Zeynep Toma and İrem Deyneli is published on Mondaq.
Human medicinal products are launched to market and made available for public use after going through a set of critical clinical trials, whereas pharmacovigilance aspect plays a crucial role in terms of ensuring the safety of such products in their lifecycle. Pharmacovigilance activities comprise of a wide range including monitoring, registering, assessing and archiving adverse effects of medicinal products and taking necessary measures with a view to minimizing any potential damages.
The piece of legislation that sets forth the main standards and the pharmacovigilance related liability is the Regulation on the Safety of Medicinal products published on the Official Gazette dated 15 April 2014 and numbered 28973 (“Regulation“). Further, with a view to keeping up with the related developments in the EU, the Turkish Medicines and Medical Devices Agency (“Authority“) has also issued a number of guidelines and modules including the Guideline on Pharmacovigilance Indicators, the Guideline on Crisis Management in Pharmacovigilance Activities, the Guidelines on the Protection of Personal Data in Pharmacovigilance Activities and the Guideline on Reliance Applications in Pharmacovigilance Activities.
You may reach the entire article here.
Share
Related persons
You can contact us for detailed information.
Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
10 September 2024
Turkish Data Protection Authority and Turkish Ministry of Trade sign cooperation protocol on targeted advertising and dark patterns
The Turkish Personal Data Protection Authority and the Turkish Ministry of Trade General Directorate of Consumer Protection and Market…
16 August 2024
Turkish Competition Law Newsletter – 2024 Summer Issue
We are pleased to share our quarterly newsletter on recent developments under Turkish Competition Law.
16 August 2024
New Regulatory Framework Unfolded for Establishment of Crypto Platforms
Following the July 2, 2024, introduction of the crypto asset regulation law under the Capital Markets Law No. 6362, the Capital Markets…
7 August 2024
Key Changes in the Local Tax Legislation
Paksoy legal briefing: “Key Changes in the Local Tax Legislation”
24 July 2024
Amendments on the Communiqué on Principles Regarding Real Estate Investment Funds
The Communiqué Amending the Communiqué on Principles Regarding Real Estate Investment Funds (III- 52.3) (“Amendment Communiqué”) has been…
18 July 2024
Turkish Data Protection Authority issues new regulation on cross-border data transfers
Paksoy legal briefing: “Turkish Data Protection Authority issues new regulation on cross-border data transfers”